These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21998075)

  • 1. Identification of fibroblast growth factor 1 (FGF-1) in a black market product.
    Walpurgis K; Thomas A; Laussmann T; Horta L; Metzger S; Schänzer W; Thevis M
    Drug Test Anal; 2011; 3(11-12):791-7. PubMed ID: 21998075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of an unknown fusion protein in confiscated black market products.
    Walpurgis K; Krug O; Thomas A; Laussmann T; Schänzer W; Thevis M
    Drug Test Anal; 2014; 6(11-12):1117-24. PubMed ID: 25219942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confiscated black market products and nutritional supplements with non-approved ingredients analyzed in the Cologne Doping Control Laboratory 2009.
    Kohler M; Thomas A; Geyer H; Petrou M; Schänzer W; Thevis M
    Drug Test Anal; 2010; 2(11-12):533-7. PubMed ID: 21204286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of His-tagged Long-R³-IGF-I in a black market product.
    Kohler M; Thomas A; Walpurgis K; Terlouw K; Schänzer W; Thevis M
    Growth Horm IGF Res; 2010 Oct; 20(5):386-90. PubMed ID: 20675162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Black market products confiscated in Norway 2011-2014 compared to analytical findings in urine samples.
    Hullstein IR; Malerod-Fjeld H; Dehnes Y; Hemmersbach P
    Drug Test Anal; 2015; 7(11-12):1025-9. PubMed ID: 26607218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and identification of a C-terminal amidated mechano growth factor (MGF) analogue in black market products.
    Esposito S; Deventer K; Van Eenoo P
    Rapid Commun Mass Spectrom; 2012 Mar; 26(6):686-92. PubMed ID: 22328223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doping control of biosimilar epoetin kappa and other recombinant erythropoietins after intravenous application.
    Okano M; Sato M; Kaneko E; Kageyama S
    Drug Test Anal; 2011; 3(11-12):798-805. PubMed ID: 22012825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometric characterization of a biotechnologically produced full-length mechano growth factor (MGF) relevant for doping controls.
    Thevis M; Thomas A; Geyer H; Schänzer W
    Growth Horm IGF Res; 2014 Dec; 24(6):276-80. PubMed ID: 25466910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fc-fragment removal allows the EPO-Fc fusion protein to be detected in blood samples by IEF-PAGE.
    Postnikov P; Krotov G; Mesonzhnik N; Efimova Y; Rodchenkov G
    Drug Test Anal; 2015; 7(11-12):999-1008. PubMed ID: 26695487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for detection and confirmation of Hematide™/peginesatide in anti-doping samples.
    Leuenberger N; Saugy J; Mortensen RB; Schatz PJ; Giraud S; Saugy M
    Forensic Sci Int; 2011 Dec; 213(1-3):15-9. PubMed ID: 21816551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the growth hormone-releasing hormone analogue [Pro1, Val14]-hGHRH with an incomplete C-term amidation in a confiscated product.
    Esposito S; Deventer K; Van Eenoo P
    Drug Test Anal; 2014; 6(11-12):1155-9. PubMed ID: 25283153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2012 Jan; 4(1):2-16. PubMed ID: 22287289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of black market products and potential doping agents in Germany 2010-2013.
    Krug O; Thomas A; Walpurgis K; Piper T; Sigmund G; Schänzer W; Laussmann T; Thevis M
    Eur J Clin Pharmacol; 2014 Nov; 70(11):1303-11. PubMed ID: 25168622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometric detection of peginesatide in human urine in doping control analysis.
    Möller I; Thomas A; Delahaut P; Geyer H; Schänzer W; Thevis M
    J Pharm Biomed Anal; 2012 Nov; 70():512-7. PubMed ID: 22884786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product.
    Thevis M; Geyer H; Kamber M; Schänzer W
    Drug Test Anal; 2009 Aug; 1(8):387-92. PubMed ID: 20355219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of peptidic erythropoiesis-stimulating agents in sport.
    Reichel C
    Br J Sports Med; 2014 May; 48(10):842-7. PubMed ID: 24677025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research.
    Beuck S; Bornatsch W; Lagojda A; Schänzer W; Thevis M
    Drug Test Anal; 2011; 3(11-12):756-70. PubMed ID: 22213684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls.
    Möller I; Wintermeyer A; Bender K; Jübner M; Thomas A; Krug O; Schänzer W; Thevis M
    Drug Test Anal; 2011 Sep; 3(9):609-20. PubMed ID: 20872894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolysis and autolysis of proteases and the detection of degradation products in doping control.
    Thomas A; Kohler M; Walpurgis K; Schänzer W; Thevis M
    Drug Test Anal; 2009 Feb; 1(2):81-6. PubMed ID: 20355180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry.
    Thomas A; Höppner S; Geyer H; Schänzer W; Petrou M; Kwiatkowska D; Pokrywka A; Thevis M
    Anal Bioanal Chem; 2011 Aug; 401(2):507-16. PubMed ID: 21298258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.